Previous research has indicated that its expression might be linked to various tumors, including bladder cancer, colon cancer, and melanoma, and it may be utilized to exhibit antitumor capabilities.[35–37] Retinol dehydrogenase 10 (RDH10) belonged to the SDR family and exhibits retinol oxidoreductase activity. This evidence concerns the gene RDH10 and urinary bladder carcinoma.